- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 01.04. | Pharma Equity Group A/S: The Board of Directors' resolution on the issuance of convertible loans | 1 | GlobeNewswire (USA) | ||
| 25.03. | Notice convening the annual general meeting in Pharma Equity Group A/S | 2 | GlobeNewswire (USA) | ||
| 20.03. | Pharma Equity Group A/S - Annual Report 2024 | 107 | GlobeNewswire (Europe) | Pharma Equity Group A/S - Annual Report 2024 Date: 20 March 2025 Announcement No. 2 Pharma Equity Group A/S - Annual Report 2024 - main features of the year The Board of Directors of Pharma Equity Group... ► Artikel lesen | |
| 28.02. | Pharma Equity Group A/S: 2025 Financial Calendar | 1 | GlobeNewswire (USA) | ||
| 14.01. | Pharma Equity Group A/S: Pharma Equity Group 2025 Financial Calendar | 2 | GlobeNewswire (USA) | ||
| 13.12.24 | Pharma Equity Group A/S: The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. | 79 | GlobeNewswire (Europe) | The Board of Directors' decision on a new execution strategy and prioritisation of clinical areas in Reponex Pharmaceuticals A/S. December 13, 2024Announcement No. 32 Pharma Equity Group... ► Artikel lesen | |
| 29.11.24 | Martin Engell-Rossen will be Head of Cabinet to Denmark's new EU Commissioner Dan Jørgensen in Brussels and will therefore resign from the Board of Directors of Pharma Equity Group A/S | 1 | GlobeNewswire (USA) | ||
| PHARMA EQUITY GROUP Aktie jetzt für 0€ handeln | |||||
| 15.11.24 | Pharma Equity Group A/S: Consolidated Interim report 1 January - 30 September 2024 | 120 | GlobeNewswire (Europe) | Consolidated Interim report 1 January - 30 September 2024 Company announcement no. 30 - November 15, 2024 Key points from the Q1-Q3-2024 report (period 1 January - 30 September 2024) On 15 November... ► Artikel lesen | |
| 23.10.24 | Pharma Equity Group A/S: Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. | 103 | GlobeNewswire (Europe) | Pharma Equity Group's subsidiary (Reponex Pharmaceuticals A/S) has obtained patent protection in Japan for the treatment of colorectal cancer with RNX-051. October 23, 2024Company Announcement... ► Artikel lesen | |
| 11.10.24 | Nasdaq Copenhagen A/S: Pharma Equity Group A/S - admittance to trading and official listing of new shares due to a directed issue | 318 | GlobeNewswire | The share capital of Pharma Equity Group A/S has been increased. The admittance
to trading and official listing of new shares will take effect as per 16
October 2024 in the ISIN below.
ISIN ... ► Artikel lesen | |
| 04.10.24 | Nasdaq Copenhagen A/S: Pharma Equity Group A/S - reduction of share capital by reduction of face value per share | 202 | GlobeNewswire | The changes below will take effect on Nasdaq Copenhagen as per 10 October 2024.
ISIN DK0061155009
--------------------------------------------------------------------------------
Name:... ► Artikel lesen | |
| 16.08.24 | Pharma Equity Group A/S: Consolidated Interim Report 1 January - 30 June 2024 | 159 | GlobeNewswire (Europe) | Consolidated Interim Report 1 January - 30 June 2024 Company announcement no. 23 - August 16, 2024 Key points from the H1-2024 report (period 1 January - 30 June 2024) On 16 August 2024, the... ► Artikel lesen | |
| 03.06.24 | Results of extraordinary general meeting in Pharma Equity Group A/S | 192 | GlobeNewswire (Europe) | Results of extraordinary general meeting in Pharma Equity Group A/S 3 June 2024Company announcement no. 19Pharma Equity Group A/S today held an extraordinary general meeting with the following... ► Artikel lesen | |
| 16.05.24 | Pharma Equity Group A/S: Consolidated interim report 1 January - 31 March 2024 | 182 | GlobeNewswire (Europe) | Consolidated interim report 1 January - 31 March 2024 Company announcement no. 17 Date: 16 May 2024 Key points from Q1-24 report (period 1 January - 31 March 2024) On 16 May 2024, the Board of... ► Artikel lesen |
14 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|
Das Unternehmen PHARMA EQUITY GROUP A/S kann der Branche Finanzdienstleistungen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu PHARMA EQUITY GROUP A/S finden Sie auf Wallstreet Online.
